A Refresher and an Update: The (Cannabis) STATES Act
It seems like every year, the old pot guard in Congress tries its hand at some form of marijuana legalization. Although these sorts of actions attract headlines (and votes?), they never seem to go anywhere. But for the first time ever, a real and legitimate bipartisan “respect states’ rights”... Read more
Support for Legal Marijuana Higher Than Ever
The industry on cannabis has become one of the fastest growing industries across the nation over the last several years. With new markets growing in and around the U.S., many polls are reporting that support for cannabis use and legalization, is higher than ever before. One of the major... Read more
Hemp, Inc. (HEMP) Commends U.S. Senate for Passing Farm Bill
Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today the company commends the U.S. Senate for passing the 2018 Farm Bill in a 86-11 vote, yesterday June 28, 2018. Bruce Perlowin, CEO of Hemp,... Read more
From Forbes: U.S. Senate Votes To Legalize Hemp After Decades-Long Ban Under Marijuana Prohibition
From Forbes.com: The non-psychoactive cannabis cousin of marijuana would finally become legal to grow in the United States under a bill overwhelmingly approved by the Senate. The wide-ranging agriculture and food policy legislation known as the Farm Bill, passed by a vote of 86 – 11 on Thursday, contains provisions to legalize the cultivation,... Read more
BREAKING NEWS: Senate Bill Introduced to End Cannabis Prohibition
Our thoughts on the new Senate cannabis bill. Yesterday, U.S. Senator Chuck Schumer (D-NY) introduced the Marijuana Freedom and Opportunity Act (“MFOA”). The MFOA is also co-sponsored by Senators Bernie Sanders (I-VT), Tim Kaine (D-VA), and Tammy Duckworth (D-IL). Coming on the heels of the STATES Act, the MFOA... Read more
Federal Laws Create a ‘Moat’ Around Marijuana Business, Says Founder of U.S. Cannabis Company
The Food and Drug Administration on June 25 approved for the first time a drug made from cannabidiol (CBD), a molecule derived from the cannabis plant. The drug, Epidiolex, was approved for the treatment of two types of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, that have been resistant to treatment. Well-designed clinical... Read more
Approval of Drug Derived From Cannabis Not Necessarily a Win for the Plant
Cleveland, OH–JUNE 24, 2018 — PRESS RELEASE — The Medical Cannabis Pioneers Picnic will be held at Rid All Green Partnership, a thriving urban farm in Cleveland, Ohio, on July 22, 2018 from 3 p.m. to 7 p.m. Guests will enjoy healthy and organic picnic fare, while several certified-to-recommend... Read more
U.S. Sen. Chuck Schumer Files Marijuana Decriminalization Bill
Deeply conservative Oklahoma became the 30th U.S. state to legalize medical marijuana after voters approved a ballot initiative by a 57-43 margin on June 26. The move signaled new inroads among Bible Belt constituencies, where, by and large, state policies have restricted medical cannabis use to hemp-derived CBD products... Read more
Federal Trademarks for Cannabis CBD? The USPTO Says No.
Official USPTO position on industrial hemp CBD marks. With the cannabidiol (CBD) industry continuing to boom, I’ve had numerous inquiries from my CBD-selling clients regarding federal trademark protection for their CBD brands, particularly when the CBD they are selling is derived from Farm Bill hemp and grown in accordance... Read more
FDA’s Approval of New Cannabis-Derived Drug Will Pave the Way for Future Medications, CEO Says
Edmonton, AB – June 26, 2018 – PRESS RELEASE – Aurora Cannabis Inc. announced today that it has agreed to a new $200 million debt facility, with a potential upsize to $250 million, with the Bank of Montreal (“BMO”). The facility will consist of a $150 million term loan and... Read more

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )